Creative Planning
GMAB icon

Creative Planning’s Genmab GMAB Stock Holding History

Creative Planning’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.27M Buy
119,169
+573
+0.5% +$15.2K ﹤0.01% 1716
2026
Q1 		$3.18M Sell
118,596
-11,987
-9% -$359K ﹤0.01% 1530
2025
Q4 		$4.02M Buy
130,583
+14,734
+13% +$459K ﹤0.01% 1165
2025
Q3 		$3.55M Buy
115,849
+50,717
+78% +$1.24M ﹤0.01% 1089
2025
Q2 		$1.35M Buy
65,132
+6,870
+12% +$141K ﹤0.01% 1621
2025
Q1 		$1.14M Sell
58,262
-48,566
-45% -$1.02M ﹤0.01% 1624
2024
Q4 		$2.23M Buy
106,828
+59,406
+125% +$1.31M ﹤0.01% 1064
2024
Q3 		$1.16M Buy
47,422
+27,353
+136% +$731K ﹤0.01% 1414
2024
Q2 		$504K Sell
20,069
-16,761
-46% -$475K ﹤0.01% 1936
2024
Q1 		$1.1M Buy
36,830
+14,088
+62% +$414K ﹤0.01% 1276
2023
Q4 		$724K Sell
22,742
-3,437
-13% -$108K ﹤0.01% 1449
2023
Q3 		$923K Buy
26,179
+6,281
+32% +$239K ﹤0.01% 1197
2023
Q2 		$756K Buy
19,898
+2,993
+18% +$119K ﹤0.01% 1285
2023
Q1 		$638K Buy
16,905
+1,868
+12% +$71.8K ﹤0.01% 1329
2022
Q4 		$637K Buy
15,037
+2,733
+22% +$113K ﹤0.01% 1292
2022
Q3 		$395K Buy
+12,304
New +$432K ﹤0.01% 1478
2021
Q1 		– Sell
-5,122
Closed -$208K – 2644
2020
Q4 		$208K Sell
5,122
-46,813
-90% -$1.75M ﹤0.01% 1876
2020
Q3 		$1.9M Buy
51,935
+224
+0.4% +$8.1K 0.01% 585
2020
Q2 		$1.75M Buy
+51,711
New +$1.41M 0.01% 545

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Creative Planning's GMAB Position: Q2 2026 in Review

Creative Planning increased its Genmab (GMAB) stake by 0.48% in Q2 2026, buying an estimated $15.2K and bringing the position to 119,169 shares worth $3.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

Creative Planning first reported a position in GMAB in Q2 2020 and has held it in 19 quarters since. The position peaked at $4.02M in Q4 2025. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Creative Planning held 119,169 shares of Genmab worth $3.27M as of Q2 2026.
  • Creative Planning bought 573 Genmab shares in Q2 2026, an estimated $15.2K.
  • Genmab made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1716 holding.
  • Creative Planning first reported a position in Genmab in Q2 2020 and has held it in 19 quarters since.
  • Creative Planning's Genmab position peaked at $4.02M in Q4 2025.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.